Randomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II)

Simple item page
dc.contributor.authorSarker, Shafiqul A.
dc.date.accessioned2014-06-24T08:45:00Z
dc.date.available2014-06-24T08:45:00Z
dc.date.issued2004
dc.identifier.otherhttp://dspace.icddrb.org/jspui/handle/123456789/5126
dc.identifier.urihttp://hdl.handle.net/123456789/5126
dc.language.isoen
dc.publisherDhaka: International Centre for Diarrhoeal Diseases Research, Bangladesh; 2004
dc.sourceICDDR,B Institutional Repository
dc.subjectClinical protocols
dc.subjectRotavirus
dc.subjectDiarrhoeal, infantile
dc.titleRandomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II)
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ICDDRBProtocol-2004-009.doc
Size:
736 KB
Format:
Adobe Portable Document Format
Download

Collections

Clinical sciences research protocols